gamtbvac
Vaccineexperimental
Clinical trial activity
3 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
2
Phase 3
1
Phase 4
0
Earliest trial started Jan 15, 2017 (NCT03255278)
Timeline
Indications
Mechanism of action
- Mycobacterium tuberculosisImmunity, active
Mycobacterium tuberculosis immunity, active
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT04975737 | Phase 3 | Nov 30, 2021 | Government of Russia |
| NCT03878004 | Phase 2 | Dec 1, 2018 | Cromos Pharma, LLC, Government of Russia |
| NCT03255278 | Phase 1 | Jan 15, 2017 | Government of Russia |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Government of Russia | Government | 3 | 3 | 3 | 2017 |
| Cromos Pharma, LLC | For profit | 1 | 0 | 1 | 2018 |
2 organizations
Page 1 / 1